Form 8-K - Current report:
SEC Accession No. 0001615219-25-000080
Filing Date
2025-07-31
Accepted
2025-07-31 17:02:18
Documents
12
Period of Report
2025-07-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 8-K flks-20250731.htm   iXBRL 8-K 28145
  Complete submission text file 0001615219-25-000080.txt   143596

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20250731.xsd EX-101.SCH 1807
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20250731_lab.xml EX-101.LAB 21689
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20250731_pre.xml EX-101.PRE 12543
14 EXTRACTED XBRL INSTANCE DOCUMENT flks-20250731_htm.xml XML 2724
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 251172572
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)